Should You Buy, Sell or Hold Petropavlovsk PLC, Petra Diamonds Limited And Centamin PLC?

Petropavlovsk PLC (LON:POG), Petra Diamonds Limited (LON:PDL) and Centamin PLC (LON:CEY) each have unique attractions.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

In today’s article I’ll ask whether the green shoots of recovery are starting to show in the gold and diamond mining sectors.

Are there any buying opportunities among these companies?

Petropavlovsk

By slashing capital expenditure and focusing on the highest-grade areas of its mines, Russian gold miner Petropavlovsk (LSE: POG) has become highly cash generative. Last year’s refinancing reduced the firm’s net debt to $707m at the end of March. Since then, cash generated from operations has enabled the firm to reduce its net debt by a further $90m, to $610m.

The group’s production is expected to be flat or slightly lower in 2016, at 460,000-500,000 ounces. However, unless the price of gold rises above its current level of $1,099/oz, Petropavlovsk’s average sale price may fall slightly from last year’s $1,178/oz. The group’s hedging coverage is coming to an end and will only cover about 15% of this year’s production at $1,116/oz. The rest will be sold at market prices.

The bullish view on Petropavlovsk is that the group’s falling debt should drive steady share price growth. However, there are risks. Petropavlovsk will eventually have to spend more to maintain its production capacity, while the pace of debt reduction could slow if the price of gold fails to rise.

Petra Diamonds

Diamond miner Petra Diamonds (LSE: PDL) looks quite cheap on a 2015/16 forecast P/E of 10.9, falling to 5.2 for 2016/17. The shares also offer an appealing forecast yield of 3.1%, rising to 5% next year.

The question is whether the firm can deliver. Petra said today that sales during the final six months of 2015 were $154m, 28% less than during the same period of 2014. Today’s figures also suggest that the group has a lot of catching up to do during the next six months if it’s to hit full-year revenue forecasts of $417m.

Petra’s production rose by 2% to 1,629,403 carats during the last six months. The group says that its calendar of diamond sales is more heavily weighted to the second half of its financial year, which runs to the end of June. This means sales should be significantly higher over the next six months, giving Petra a chance of meeting its full-year forecasts.

Petra shares have edged higher this morning, suggesting the City agrees with the firm’s outlook.

Centamin

Egypt-based gold miner Centamin (LSE: CEY) is a rare beast — it’s a low-cost gold miner with rising net cash and stable profits.

The group’s legal troubles — which at one point appeared to threaten the loss of its mining licence — are still rumbling on. However, they now seem so far in the past that I suspect many investors have forgotten about them.

Is this wise? I’ve no way of knowing how the legal case against Centamin will be resolved. Past reports did suggest that the original case was politically motivated, and that a shift to a friendlier regime has neutralised the threat to the company. But there is still some risk.

Centamin stock trades on a 2015 forecast P/E of 13, falling to 12.2 for 2016. The shares offer a 2.6% forecast yield. With all-in sustaining costs of just $900 per ounce of gold, Centamin should remain profitable. I think the shares are fully valued and probably rate as a hold.

Roland Head has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »